相关实验视频

Updated: Jan 16, 2026

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

在机械门更换后,帕尔沃病毒B19诱导的无塑性贫血

Xiantao Ma¹, Ningxin Hou², Chenhe Li²

¹Division of Cardiothoracic and Vascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.

The Journal of international medical research

|September 25, 2025

概括

人类帕尔沃病毒B19可以在心脏手术后导致成人严重的无形性贫血. 早期诊断需要考虑手术后泛细胞衰竭的病毒原因,即使有合格的心脏门.

科学领域:

血液学血液学血液学
病毒学病毒学
心脏病学心脏病学

背景情况:

人类帕沃病毒B19感染通常会在免疫能力强的成年人中引起轻微症状.
严重的无塑性贫血是一种罕见的并发症,通常是短暂的.
机械门置换后的手术后的胰岛素减肥症带来了诊断上的挑战.

研究的目的:

在心脏切开术后的患者中报告一种由人类帕尔沃病毒B19引起的重复性严重无形性贫血的独特病例.
强调在术后细胞衰竭中考虑病毒病因的重要性.
强调多式实验室相关性,以准确诊断.

主要方法:

综合实验室评估,包括乳酸脱酶,哈普托格洛宾和网细胞生产指数.
人类帕沃病毒B19的DNA测试.
连续回声心脏图以评估假体门的功能.
周围血液涂抹分析.

主要成果:

患者呈现了尽管有功能假体门,但却呈现了渐进性的泛细胞衰竭.
升高的LDH和无法检测的平分球蛋白最初表明机械血解.
抑制的视网细胞生产指数和阳性帕尔沃病毒B19DNA证实了病毒髓抑制.
缺少分裂细胞和稳定的血红素尿排除了与假相关的血液溶解.

结论:

人类帕尔沃病毒B19应考虑在术后泛细胞减小的差异诊断中,无论免疫状况如何.
与正常血液溶解标志物的不成比例的网细胞衰减可能表明病毒透到髓.
仅靠心声学可能无法排除亚临床血液溶解,需要综合实验室评估.

关键词:

案例报告案例报告没有无形性贫血.心脏门手术心脏门手术帕尔沃病毒B19 B19

更多相关视频

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

Published on: February 4, 2021

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

相关概念视频

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

Hemodialysis I: Introduction

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...